Evidence map›Paper›PMID 33739386›Full record

ArticleCerebral cortex (New York, N.Y. : 1991)2021

Inhibition of Matrix Metalloproteinase 9 Activity Promotes Synaptogenesis in the Hippocampus.

Ahmad Salamian, Diana Legutko, Klaudia Nowicka, Bogna Badyra, Paulina Kaźmierska-Grębowska, Bartosz Caban, Tomasz Kowalczyk, Leszek Kaczmarek, Anna Beroun

Erratum issuedOpen access · hybridAbstract read
In one paragraph

Article in Cerebral cortex (New York, N.Y. : 1991), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.4field-weighted citation impact, top 48% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Dynamic Organization of Neuronal Extracellular Matrix Revealed by HaloTag-HAPLN1.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2024
    Article
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Ahmad SalamianLaboratory of Neurobiology, Nencki-EMBL Center of Excellence for Neural Plasticity and Brain Disorders: BRAINCITY, Nencki Institute of Experimental Biology of the Polish Academy of Sciences, Warsaw 02-093, Poland.
Diana LegutkoLaboratory of Neurobiology, Nencki-EMBL Center of Excellence for Neural Plasticity and Brain Disorders: BRAINCITY, Nencki Institute of Experimental Biology of the Polish Academy of Sciences, Warsaw 02-093, Poland.
Klaudia NowickaLaboratory of Neurobiology, Nencki-EMBL Center of Excellence for Neural Plasticity and Brain Disorders: BRAINCITY, Nencki Institute of Experimental Biology of the Polish Academy of Sciences, Warsaw 02-093, Poland.
Bogna BadyraLaboratory of Neurobiology, Nencki-EMBL Center of Excellence for Neural Plasticity and Brain Disorders: BRAINCITY, Nencki Institute of Experimental Biology of the Polish Academy of Sciences, Warsaw 02-093, Poland.
Paulina Kaźmierska-GrębowskaDepartment of Neurobiology, Faculty of Biology and Environmental Protection, University of Lodz, Lodz 90-236, Poland.
Bartosz CabanDepartment of Neurobiology, Faculty of Biology and Environmental Protection, University of Lodz, Lodz 90-236, Poland.
Tomasz KowalczykDepartment of Neurobiology, Faculty of Biology and Environmental Protection, University of Lodz, Lodz 90-236, Poland.
Leszek KaczmarekLaboratory of Neurobiology, Nencki-EMBL Center of Excellence for Neural Plasticity and Brain Disorders: BRAINCITY, Nencki Institute of Experimental Biology of the Polish Academy of Sciences, Warsaw 02-093, Poland.
Anna BerounLaboratory of Neurobiology, Nencki-EMBL Center of Excellence for Neural Plasticity and Brain Disorders: BRAINCITY, Nencki Institute of Experimental Biology of the Polish Academy of Sciences, Warsaw 02-093, Poland.ORCID 0000-0003-4376-5241
Instytut Biologii Doświadczalnej im. Marcelego Nenckiego · PLUniversity of Łódź · PL

Funding

European Regional Development FundFoundation for Polish Science MAB/2018/10International Research Agendas programmeNational Science Centre 2017/26/A/NZ3/00379
6 · The paper itself

Abstract

Information coding in the hippocampus relies on the interplay between various neuronal ensembles. We discovered that the application of a cholinergic agonist, carbachol (Cch), which triggers oscillatory activity in the gamma range, induces the activity of matrix metalloproteinase 9 (MMP-9)-an enzyme necessary for the maintenance of synaptic plasticity. Using electrophysiological recordings in hippocampal organotypic slices, we show that Cch potentiates the frequency of miniature inhibitory and excitatory postsynaptic currents (mIPSCs and mEPSCs, respectively) in CA1 neurons and this effect is MMP-9 dependent. Interestingly, though MMP-9 inhibition prevents the potentiation of inhibitory events, it further boosts the frequency of excitatory mEPSCs. Such enhancement of the frequency of excitatory events is a result of increased synaptogenesis onto CA1 neurons. Thus, the function of MMP-9 in cholinergically induced plasticity in the hippocampus is to maintain the fine-tuned balance between the excitatory and the inhibitory synaptic transmission.

Indexed as

AnimalsCA1 Region, HippocampalCarbacholCholinergic AgonistsExcitatory Postsynaptic PotentialsHippocampusMatrix Metalloproteinase 9Matrix Metalloproteinase InhibitorsNeurogenesisNeuronal PlasticityPatch-Clamp TechniquesRatsCarbacholCholinergic AgonistsMatrix Metalloproteinase 9Matrix Metalloproteinase InhibitorsMmp9 protein, ratcarbacholexcitatoryinhibitoryMMP-9synaptogenesis

Identifiers

PMID33739386
PMCPMC8258443
OpenAlexW3138417918

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.